Testosterone treatment for men with chronic heart failure
Open accessAbstract
Objective. To examine the impact of implementation of the Accreditation Council for Pharmacy Education9s (ACPE9s) Standards 2007 on pharmacy students’ preparation for their first advanced pharmacy practice experience (APPE). Design. The doctor of pharmacy (PharmD) curriculum was altered to include introductory pharmacy practice experiences (IPPE), second-year therapeutics, classroom integration of practice experiences, more biomedical sciences, an electronic portfolio system, life-long learning exercises, and additional content based on Appendix B of Standards 2007. Curricular outcomes and the assessment plan also were revised based on Standards 2007. Assessment. To evaluate the impact of these changes to the curriculum, faculty members rated 9 behaviors of students observed during the third week of their first APPE and compared their scores with those of students who were evaluated in 2004 before the curriculum had been revised. Students completing the revised curriculum performed all 9 behaviors more often and had a better average score than students evaluated in 2004. Conclusion. Curricular revisions implemented to address ACPE Standards 2007 were associated with positive clinical behaviors in students beginning their experiential education.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In men with chronic heart failure, exercise capacity increases after 12 weeks of testosterone treatment, while cardiac index increases after 180 min.
“Exercise capacity in men with chronic heart failure increased after 12 weeks (60), whereas the cardiac index (cardiac output related to body surface) had already increased after 180 min.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [60]
There is some evidence that testosterone replacement is beneficial and improves functional status in men with chronic heart failure.
“there is some evidence that testosterone replacement is beneficial and improves functional status in men with CHF [5,6].”
From The Effect of Testosterone on Insulin Sensitivity in Men with Heart Failure (2007) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Development of a shuttle walking test of disability in patients with chronic airways obstruction.
Singh, S., Morgan, M. D., Scott, S., Walters, D., & Hardman, A. E. (1992) · Thorax · doi:10.1136/thx.47.12.1019 · Cited by 1,435 · see citing works
Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study
Wang, C., Alexander, G. M., Berman, N., Salehian, B., Davidson, T., McDonald, V., Steiner, B., Hull, L., Callegari, C. C., & Swerdloff, R. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855804 · Cited by 453 · see citing works
Acute haemodynamic effects of testosterone in men with chronic heart failure
Pugh, P. J. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00083-6 · Cited by 184 · see citing works
Self-citationDevelopment of a Shuttle Walking Test of Disability in Patients with Chronic Airways Obstruction
Singh, S. J., Morgan, M. J., Scott, S. M., Walters, D., & Hardman, A. E. (1993) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199305000-00014 · Cited by 178 · see citing works
PITUITARY‐GONADAL DYSFUNCTION IN LOW‐OUTPUT CARDIAC FAILURE
TAPPLER, B., & Katz, M. (1979) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1979.tb02075.x · Cited by 41 · see citing works
Heart Failure as an Inflammatory Condition: Potential Role for Androgens as Immune Modulators
Pugh, P. J., Jones, R. D., Jones, T. H., & Channer, K. S. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00162-9 · Cited by 36 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731 · see citing works
Self-citationCaminiti, G., Volterrani, M., Iellamo, F., Marazzi, G., Massaro, R., Miceli, M., Mammi, C., Piepoli, M., Fini, M., & Rosano, G. M. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.078 · Cited by 444 · see citing works
Malkin, C. J., Pugh, P. J., West, J. N., van Beek, E. J. R., Jones, T. H., & Channer, K. S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi443 · Cited by 413 · see citing works
Self-citationAndrogens, insulin resistance and vascular disease in men
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02299.x · Cited by 317 · see citing works
Self-citationTestosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292 · see citing works
Self-citationOnset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232 · see citing works
Testosterone replacement therapy: current trends and future directions
Nieschlag, E., Behre, H. M., Bouchard, P., Corrales, J. J., Jones, T. H., Stalla, G. K., Webb, S. M., & Wu, F. C. W. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh035 · Cited by 224 · see citing works
Self-citationEndocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221 · see citing works
Treatment of Men for “Low Testosterone”: A Systematic Review
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162480 · Cited by 97 · see citing works
The Effect of Testosterone on Insulin Sensitivity in Men with Heart Failure
Malkin, C. J., Jones, T. H., & Channer, K. S. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.04.006 · Cited by 84 · see citing works
Self-citationEffect of testosterone on <i>ex vivo</i> vascular reactivity in man
Malkin, C. J., Jones, R. D., Jones, T. H., & Channer, K. S. (2006) · Clinical Science · doi:10.1042/cs20050354 · Cited by 81 · see citing works
Self-citationKolind, M. I., Christensen, L. L., Caserotti, P., Andersen, M. S., & Glintborg, D. (2022) · Andrology · doi:10.1111/andr.13147 · Cited by 12 · see citing works
- Authors
- Pugh, P. J., Jones, R. D., West, J. N., Jones, T. H., & Channer, K. S.
- Affiliations
- Royal Hallamshire Hospital (GB)
- University of Sheffield (GB)
- Corresponding author
- Channer, K S
- ORCID
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2004-03-12
- Volume
- 90
- Issue
- 4
- Pages
- 446-447
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- PMC
- PMC1768161
- OpenAlex
- W2091378637
- Cited by
- 221
- References
- 6
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 12 · 2021: 9 · 2020: 9 · 2019: 11 · 2018: 10 · 2017: 13 · 2016: 10 · 2015: 10 · 2014: 13 · 2013: 17 · 2012: 11
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Heart (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- testosterone replacement therapy, chronic heart failure, men, advanced pharmacy practice experience, pharmacy curriculum, pharmacy students, experiential education, clinical behavior
- MeSH terms
- Adult, Aged, Aged, 80 and over, Androgens, Chronic Disease, Double-Blind Method, Heart Failure, Humans, Male, Middle Aged, Pilot Projects, Testosterone, Exercise Tolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
